With a market cap of $8.5 billion, Pentair plc (PNR) is a global leader in smart, sustainable water solutions that help the world move, improve, and enjoy water across residential, commercial, and industrial applications. With approximately 9,000 employees serving customers in over 150 countries, the company focuses on delivering impactful technologies that help people and the planet thrive.
The London, the United Kingdom-based company is expected to release its fiscal Q3 2026 results soon. Ahead of the event, analysts project PNR to report an adjusted EPS of $1.08, a 12.9% decline from $1.24 in the year-ago quarter. However, the company has exceeded Wall Street's bottom-line estimates in each of the last four quarters.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
For fiscal 2026, analysts forecast Pentair to post adjusted EPS of $4.64, down 5.7% from $4.92 in fiscal 2025. Nevertheless, adjusted EPS is expected to grow 9.7% year-over-year to $5.09 in fiscal 2027.
www.barchart.com Shares of Pentair have decreased 52.1% over the past 52 weeks, underperforming the broader S&P 500 Index's ($SPX) 15.2% return and the State Street Industrial Select Sector SPDR ETF's (XLI) 8.9% gain over the same period.
www.barchart.com Pentair has underperformed due to a sharper-than-expected inventory correction and ongoing destocking in its pool channel, which forced management to lower its full-year sales and earnings guidance significantly. The company’s pool segment has also suffered from market share losses to major peers, raising concerns that relying on pricing actions will squeeze profit margins if volume growth fails to rebound.
Analysts' consensus view on PNR stock is cautiously optimistic, with a "Moderate Buy" rating overall. Among 18 analysts covering the stock, seven suggest a "Strong Buy," one "Moderate Buy," six give a "Hold," one has a "Moderate Sell," and three provide a "Strong Sell" rating. This configuration is less bullish than three months ago, with 11 analysts suggesting a "Strong Buy."
The average analyst price target is $78.62, suggesting a potential upside of 48.4% fro current levels.
On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
This Healthcare Stock Just Raised Its Dividend by Nearly 15%. Eli Lilly vs. Novo: The Hidden Battle Behind the Weight-Loss Platform Reshaping Industries Micron Just Reported Earnings in the Middle of a Memory Shortage. Here Are the Numbers You Need to Know. This Analyst Just Downgraded Moderna Stock. Here's Why.